Abstract:Aims: Colorectal cancer (CRC) has high mortality and morbidity rates; however, the mechanism of CRC cells uncontrolled proliferation is unclarified, E3 ligases are widely reported to have crucial functions in cancers. HERC3 was once recognized as an important role in CRC, however its effects on CRC cell proliferation and cell cycle are blank. Methods: Correlation between HERC3 and clinical characteristics was analyzed. Coimmunoprecipitation, mass spectrometry analysis and GST-pull down were performed to identify interacting-proteins of HERC3. Expression pattern of RPL23A and its correlation between HERC3 was researched via qRT-PCR, western blot and immunohistochemistry. In vivo and vitro gain-and loss-of-function assays and rescue experiments concentrating HERC3-RPL23A axis in terms of cell proliferation and cell cycle were conducted. The ubiquitination regulatory mechanism between HERC3 and RPL23A were identified via vivo ubiquitylation assays, cycloheximide analysis and mass spectrometry analysis. GSEA aided to research the potential functional mechanism of RPL23A and validated by western blot and in vivo ubiquitylation assays. Results: HERC3 expression decreased gradually from colorectal tissues in healthy individuals to adjacent-tumors normal tissue in CRC patients, and to tumor tissues and HERC3 could inhibit CRC cell proliferation and arrest cells in the G0-G1 phase. RPL23A which was recognized as one potential target of HERC3 was identified to be overexpressed in CRC and could serve as a prognostic biomarker in CRC. RPL23A could also independently regulate the cell cycle and cell proliferation and attenuate the influence of HERC3 on CRC. In addition, HERC3 directly interacted with RPL23A and served as an E3 ligase to ubiquitination degrade RPL23A via K48-dependant manner through the HECT domain. Furthermore, HERC3 could regulate the ubiquitination of p21 and further modulate protein expression of c-Myc and p21 via regulating RPL23A. Conclusion: HERC3 controlled CRC proliferation, the cell cycle and regulated the c-Myc/p21 axis via directly targeting RPL23A for ubiquitination degradation.

Inhibiting eIF3I's Degradation of Ubiquitin-Proteasome Promote Proliferation in Hela

Promotive Effect of Decreased Cyclin E Threshold on Cell Proliferation

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

HERC3 Directly Targets RPL23A for Ubiquitination Degradation and Further Regulates Colorectal Cancer Proliferation and the Cell Cycle

Inhibitory Effect of Cucurbitacin E on the Proliferation of Breast Cancer Cells and Its Mechanism

E2F1 Transactivates IQGAP3 and Promotes Proliferation of Hepatocellular Carcinoma Cells Through IQGAP3-mediated PKC-alpha Activation.

Identification of the p28 subunit of eukaryotic initiation factor 3(eIF3k) as a new interaction partner of cyclin D3.

Small-molecule induction of phospho-eIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue.

Deubiquitinase DUB3 Regulates Cell Cycle Progression via Stabilizing Cyclin A for Proliferation of Non-Small Cell Lung Cancer Cells

USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis

The E3 ubiquitin ligase HECTD1 contributes to cell cycle progression through an effect on mitosis

UBE2M Promotes Cell Proliferation Via the Β-Catenin/cyclin D1 Signaling in Hepatocellular Carcinoma

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis

The Over-Expression of P53 H179Y Residue Mutation Causes the Increase of Cyclin A1 and Cdk4 Expression in HELF Cells

Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling.

EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation

eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content

Up-regulation of EIF3e is Associated with the Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients.

EIF3B promotes cancer progression in pancreatic cancer

E3 ligase MG53 suppresses tumor growth by degrading cyclin D1